Skip to content

CSBR

Champions Oncology, Inc.

NASDAQ · Healthcare · Biotechnology · US

$5.22
−1.14%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-10.6%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jan 30, 2026Brainin Robert Lawrence · director, officer: CEOA-Award100,000$7.80
Jan 30, 2026Brainin Robert Lawrence · director, officer: CEOA-Award150,000$7.80
Jan 30, 2026Brainin Robert Lawrence · director, officer: CEOA-Award62,500$7.80
Jan 30, 2026Brainin Robert Lawrence · director, officer: CEOA-Award225,000$7.80
Jan 30, 2026Brainin Robert Lawrence · directorA-Award23,030$4.64
Jan 30, 2026Brainin Robert Lawrence · directorA-Award19,070$5.51
Jan 30, 2026Brainin Robert Lawrence · directorA-Award14,130$7.00
Jan 30, 2026Brainin Robert Lawrence · directorA-Award9,901$10
Nov 7, 2025Breitfeld Philip P. · directorA-Award13,790$6.80
Nov 7, 2025SIDRANSKY DAVID · directorA-Award21,216$6.80
Nov 7, 2025Mendelson Daniel Newman · directorA-Award13,790$6.80
Nov 7, 2025TOBIN SCOTT R · director, 10 percent owner: A-Award25,460$6.80
Nov 7, 2025ACKERMAN JOEL · directorA-Award21,216$6.80
Nov 6, 2025ACKERMAN JOEL · directorM-Exempt94,405$2.10
Nov 18, 2024Breitfeld Philip P. · directorA-Award18,715$4.64
Nov 18, 2024SIDRANSKY DAVID · directorA-Award21,880$4.64
Nov 18, 2024Mendelson Daniel Newman · directorA-Award21,590$4.64
Nov 18, 2024TOBIN SCOTT R · director, 10 percent owner: A-Award34,550$4.64
Nov 18, 2024ACKERMAN JOEL · directorA-Award43,190$4.64
Nov 1, 2024ACKERMAN JOEL · directorM-Exempt16,667$5.43
Nov 1, 2024ACKERMAN JOEL · directorM-Exempt88,470$2.10
Apr 1, 2024Davis Brady · officer: PresidentA-Award68,000$6.50
Apr 1, 2024Davis Brady · officer: PresidentA-Award7,500$6.50
Apr 1, 2024Davis Brady · officer: PresidentA-Award135,000$6.50
Jan 16, 2024Mendelson Daniel Newman · directorPurchase1,000$6.50
Jan 12, 2024Mendelson Daniel Newman · directorPurchase2,000$6.27
Jan 11, 2024Mendelson Daniel Newman · directorPurchase2,944$6.31
Jan 10, 2024Mendelson Daniel Newman · directorPurchase3,000$6.25
Jan 9, 2024Mendelson Daniel Newman · directorPurchase1,000$6.15
Jan 8, 2024Mendelson Daniel Newman · directorPurchase2,000$6.09
Institutional positioning

13F filings over the trailing two quarters

New 5Increased 4Reduced 8Sold out 26
FilerActionSharesFiled
BATTERY MANAGEMENT CORP.Unchanged2,421,673May 15, 2026
NEA MANAGEMENT COMPANY, LLCUnchanged1,713,720May 15, 2026
TOCQUEVILLE ASSET MANAGEMENT L.P.Unchanged319,674May 12, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position299,520May 15, 2026
MORGAN STANLEYReduced242,300May 15, 2026
RENAISSANCE TECHNOLOGIES LLCReduced145,539May 14, 2026
BLACKROCK, INC.Increased123,900May 13, 2026
MINK BROOK ASSET MANAGEMENT LLCIncreased111,338Apr 1, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased77,177May 15, 2026
NORTHERN TRUST CORPReduced45,932May 14, 2026
HIGHTOWER ADVISORS, LLCUnchanged35,158May 5, 2026
VANGUARD FIDUCIARY TRUST CONew Position32,992May 8, 2026
STATE STREET CORPUnchanged26,203May 15, 2026
DIMENSIONAL FUND ADVISORS LPReduced23,973May 7, 2026
JANE STREET GROUP, LLCReduced23,200May 12, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jan 30, 2026